Please login to the form below

Sandoz

This page shows the latest Sandoz news and features for those working in and with pharma, biotech and healthcare.

Novartis weathers the COVID-19 storm in Q3, lifts outlook

Novartis added that COVID-19 had negatively impacted some areas of the business, particularly in its dermatology, ophthalmology and Sandoz retail business units.

Latest news

US charges Teva for generic drug price-fixing plot

A total of 20 pharma companies were cited in the lawsuit – including Teva, Novartis’ Sandoz unit, Mylan and Pfizer – which are accused of ‘multi-billion dollar fraud’. ... Other drugmakers indicted in the wide-ranging probe, including Apotex
Novartis’ Sandoz division announces antibiotic manufacturing plan

Although the Sandoz agreement does not include the development of next-generation antibiotic medicines, it does signal an acknowledgement of the importance of this class of drugs. ... Novartis is committed to sustaining a resilient and competitive supply
Novartis stumbles in Q2 as COVID-19 impacts sales

Net sales from Novartis’ generics division Sandoz also dropped by 9% to $2.2bn, which the company attributed to negative impacts from COVID-19, and a slowdown in the medicine stockpiling
Novartis reveals plans for a zero-profit COVID-19 drugs portfolio

The ‘Novartis COVID-19 portfolio’ is comprised of 15 medicines from its generics division, Sandoz, for the treatment of gastro-intestinal illness, acute respiratory symptoms, pneumonia and septic shock.
FDA grants emergency authorisation to chloroquine for COVID-19

Sandoz, the generics division of pharma giant Novartis has already donated 30 million doses of hydroxychloroquine to the stockpile while German pharma company Bayer has donated one million doses of chloroquine.

More from news
Approximately 28 fully matching, plus 180 partially matching documents found.

Latest Intelligence

Growing evidence supports the important role of biosimilars in healthcare

The study, conducted by Sandoz, shows that using biosimilar Zarxio (filgrastim- sndz) as primary prophylaxis after the first cycle of adjuvant docetaxel chemotherapy (an intermediate-risk regimen) in the treatment of ... Edward Li is Director, Health
The US celebrates five years of biosimilars on the market – a look to the past, present and future

patients. Responding to this need, Sandoz developed two educational campaigns – The Biosimilars Generation in Canada and The ABCs of Biosimilars in the US – to educate the public about the safety, efficacy ... Robert Spina is VP of Key Accounts
Deal Watch October 2018

radioligands and CAR‐T for cancer. $2.1B. Sale. Aurobindo. NovartIs sold part of Sandoz’s US generics. ... Sandoz’s US business has retained its biosimilars, value‐added medicines and complex generics, including the ophthalmology products.
Innovation in merger control and the impact on the pharmaceutical sector

In Ciba-Geigy/Sandoz, the FTC was concerned that the merger could impair the development of gene therapy, a market that the FTC forecast to be worth US$45bn within 20 years
Building a bright future

Mylan’s biosimilar of the multiple sclerosis injection therapy copaxane is not gliding to the promised land, and delays have given rivals Momenta and Novartis’ Sandoz a tilt at the

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

BMS appoints new commercial leader, Davies joins Eisai and more

Prior to this, she has held roles for TEVA, Sandoz, Aventis and Johnson &Johnson.
Novartis changes executive committee

Klinger initially joined Novartis back in 2011 as general counsel, North America for its biopharmaceutical arm Sandoz.
Hansa Medical poaches Vifor Pharma’s CEO

Additionally, Tulstrup has served as CEO of Santaris Pharma, now part of Roche, and in several senior commercial roles within Merck &Co and Sandoz Pharma.
AXON picks Andrew Martello to lead new Brighton office

Martello’s career has seen him serve in various positions for GlaxoSmithKline, Abbott Laboratories and Sandoz, and work agency-side at Sciterion and Spoonful of Sugar.
Swiss Biotech Association appoints Michael Altorfer as CEO

His other roles include scientists for Roche and Sandoz and he has held programme management and line management roles at the investment banking firm UBS Warburg.

More from appointments
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest from PMHub

Innovative NHS suppliers scoop HSJ Partnership Awards

Best Pharmaceutical Partnership with the NHS: Winner, Merck, Sharp and Dohme Ltd; highly commended, Sandoz UK.
Leading NHS suppliers highlighted in shortlist for new HSJ awards

Novo Nordisk. Amgen and UCLH Cancer Collaborative. Bayer. Sandoz UK. Napp Pharmaceuticals.
Sandoz International GmbH

Sandoz is a world leader in generic pharmaceuticals, finding innovative ways to making medicines affordable and accessible to more than 90 percent of the world’s population. ... Sandoz International GmbH.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Healthcare Lead Copywriter: Competitive

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Medical Editor: Competitive

Healthcare Senior Account Manager: Competitive

Account Director – Creative Healthcare Communications: Competative

Healthcare Account Director: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

PMHub

Add my company

Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

2020 - a year to remember or forget?: 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
The search for effective drug treatments for COVID-19: PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...